| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| vx 548 | 0.04 | 0.3 | 6686 | 80 |
| vx 548 clinical trial | 1.66 | 0.7 | 1530 | 34 |
| vx 548 vertex | 0.76 | 0.6 | 2512 | 47 |
| vx 548 inhibitor | 0.66 | 0.2 | 1470 | 72 |
| vx 548 phase 3 | 1.45 | 0.1 | 2102 | 59 |
| vx 548 neuropathic pain | 1.91 | 0.4 | 6555 | 48 |
| vx 548 nejm | 0.86 | 0.6 | 8200 | 58 |
| vx 548 reddit | 0.24 | 0.9 | 9455 | 44 |
| vx-548 preclinical | 0.27 | 0.3 | 3580 | 9 |
| vx-548 mechanism of action | 0.4 | 0.8 | 5687 | 43 |
| vx 880 clinical trial | 1.03 | 0.4 | 3917 | 95 |
| vx-548 phase 1 | 0.22 | 0.6 | 1167 | 13 |
| vx-548 patent | 0.93 | 0.7 | 4289 | 95 |
| vx-548 phase 3 | 0.16 | 0.6 | 6285 | 98 |
| what is in vx-548 | 0.14 | 0.9 | 362 | 1 |
| vx-548 review | 0.56 | 0.1 | 181 | 60 |
| vx-548 structure | 0.39 | 0.6 | 1772 | 37 |
| cx 5461 clinical trial | 1.18 | 0.8 | 8747 | 81 |
| vx-548 cas | 0.8 | 1 | 4702 | 23 |
| chemical structure of vx-548 | 0.49 | 0.1 | 4153 | 23 |
| vx-548 selectivity | 1.25 | 0.8 | 9098 | 7 |
| vtx-548 | 1.85 | 0.2 | 7197 | 66 |
| vx-548 pk | 0.73 | 0.4 | 3875 | 1 |
| vx-548 mce | 0.92 | 0.2 | 2504 | 52 |
| vx-548 ic50 | 0.45 | 0.5 | 2729 | 62 |
| vx-548 vertex | 1.55 | 0.9 | 9442 | 60 |
| vx-548 suzetrigine | 0.19 | 0.3 | 4969 | 37 |
